| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50447-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61817-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-22400-0.05mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-37432-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2718SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35071-1mg | |||
| Carrier-Free | NBP2-35071-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61719-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61693-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP1-97515-0.025mg | |||
![Western Blot: PXR/NR1I2 Antibody (6H11D8) [NBP2-61817] - Analysis using NR1I2 mAb against human NR1I2 (AA: 1-142) recombinant protein. (Expected MW is 42.2 kDa)](http://images.novusbio.com/fullsize/PXR-NR1I2-Antibody-6H11D8-Western-Blot-NBP2-61817-img0003.jpg "Western Blot: PXR/NR1I2 Antibody (6H11D8) [NBP2-61817] - Analysis using NR1I2 mAb against human NR1I2 (AA: 1-142) recombinant protein. (Expected MW is 42.2 kDa)")
![Western Blot: PXR/NR1I2 Antibody (6H11D8) [NBP2-61817] - Analysis using NR1I2 mAb against HEK293 (1) and NR1I2 (AA: 1-142)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/PXR-NR1I2-Antibody-6H11D8-Western-Blot-NBP2-61817-img0004.jpg)
![ELISA: PXR/NR1I2 Antibody (6H11D8) [NBP2-61817] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/PXR-NR1I2-Antibody-6H11D8-ELISA-NBP2-61817-img0001.jpg)
![ELISA: PXR/NR1I2 Antibody (6H11D8) [NBP2-61817] - Analysis of HepG2 cells using NR1I2 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/PXR-NR1I2-Antibody-6H11D8-ELISA-NBP2-61817-img0002.jpg)
![Western Blot: Hsp47 Antibody (1C4-1A6) [NBP2-22400] - analysis of Human Epithelial cell (A431) lysates showing detection of 47 kDa Hsp47 protein using Mouse Anti-Hsp47 Monoclonal Antibody, Clone 1C4-1A6 . Lane 1: MW ladder. Lane 2: Anti-Hsp47 (1:250). Lane 3: Anti-Hsp47 (1:500). Lane 4: Anti-Hsp47 (1:1000). Load: 20 ug. Block: 5% milk + TBST for 1 hour at RT. Primary Antibody: Mouse Anti-Hsp47 Monoclonal Antibody at 1:250 - 1:1000 for 1 hour at RT. Secondary Antibody: HRP Goat Anti-Mouse at 1:50 for 1 hour at RT. Color Development: TMB solution for 10 min at RT. Predicted/Observed Size: 47 kDa.](http://images.novusbio.com/fullsize/Hsp47-Antibody-1C4-1A6-Western-Blot-NBP2-22400-img0001.jpg "Western Blot: Hsp47 Antibody (1C4-1A6) [NBP2-22400] - analysis of Human Epithelial cell (A431) lysates showing detection of 47 kDa Hsp47 protein using Mouse Anti-Hsp47 Monoclonal Antibody, Clone 1C4-1A6 . Lane 1: MW ladder. Lane 2: Anti-Hsp47 (1:250). Lane 3: Anti-Hsp47 (1:500). Lane 4: Anti-Hsp47 (1:1000). Load: 20 ug. Block: 5% milk + TBST for 1 hour at RT. Primary Antibody: Mouse Anti-Hsp47 Monoclonal Antibody at 1:250 - 1:1000 for 1 hour at RT. Secondary Antibody: HRP Goat Anti-Mouse at 1:50 for 1 hour at RT. Color Development: TMB solution for 10 min at RT. Predicted/Observed Size: 47 kDa.")
![Immunocytochemistry/Immunofluorescence: Hsp47 Antibody (1C4-1A6) [NBP2-22400] - Tissue: Heat Shocked HeLa Cells. Species: Human. Fixation: 2% Formaldehyde for 20 min at RT. Primary Antibody: Mouse Anti-Hsp47 Monoclonal Antibody at 1:100 for 12 hours at 4C. Secondary Antibody: FITC Goat Anti-Mouse (green) at 1:200 for 2 hours at RT. Counterstain: DAPI (blue) nuclear stain at 1:40000 for 2 hours at RT. Localization: Endoplasmic reticulum lumen. Cytoplasm. Magnification: 100x.](http://images.novusbio.com/fullsize/Hsp47-Antibody-1C4-1A6-Immunocytochemistry-Immunofluorescence-NBP2-22400-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: Hsp47 Antibody (1C4-1A6) [NBP2-22400] - Tissue: Heat Shocked HeLa Cells. Species: Human. Fixation: 2% Formaldehyde for 20 min at RT. Primary Antibody: Mouse Anti-Hsp47 Monoclonal Antibody at 1:100 for 12 hours at 4C. Secondary Antibody: APC Goat Anti-Mouse (red) at 1:200 for 2 hours at RT. Counterstain: DAPI (blue) nuclear stain at 1:40000 for 2 hours at RT. Localization: Endoplasmic reticulum lumen. Cytoplasm. Magnification: 20x.](http://images.novusbio.com/fullsize/Hsp47-Antibody-1C4-1A6-Immunocytochemistry-Immunofluorescence-NBP2-22400-img0003.jpg)
![Western Blot: Pancreatic Polypeptide/PP Antibody (2G5D12) [NBP2-37432] - Western blot analysis using PPY mAb against human PPY recombinant protein. (Expected MW is 35.9 kDa)](http://images.novusbio.com/fullsize/Pancreatic-Polypeptide-PP-Antibody-2G5D12-Western-Blot-NBP2-37432-img0002.jpg "Western Blot: Pancreatic Polypeptide/PP Antibody (2G5D12) [NBP2-37432] - Western blot analysis using PPY mAb against human PPY recombinant protein. (Expected MW is 35.9 kDa)")
![Flow Cytometry: Pancreatic Polypeptide/PP Antibody (2G5D12) [NBP2-37432] - Flow cytometric analysis of HepG2 cells using PPY mouse mAb (green) and negative control (purple).](http://images.novusbio.com/fullsize/Pancreatic-Polypeptide-PP-Antibody-2G5D12-Flow-Cytometry-NBP2-37432-img0003.jpg)
![ELISA: Pancreatic Polypeptide/PP Antibody (2G5D12) [NBP2-37432] - Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng);](http://images.novusbio.com/fullsize/Pancreatic-Polypeptide-PP-Antibody-2G5D12-ELISA-NBP2-37432-img0001.jpg)
![Western Blot: FoxD3 Antibody (5G9) [NBP1-51685] - Analysis using FOXD3 mouse mAb against NTERA-2 (1), HUVE-12 (2), HEK293 (3), Hela (4), Jurkat (5), K562 (6), RAW264.7 (7), NIH/3T3 (8), and COS7 (9) cell lysate.](http://images.novusbio.com/fullsize/FoxD3-Antibody-5G9-Western-Blot-NBP1-51685-img0002.jpg "Western Blot: FoxD3 Antibody (5G9) [NBP1-51685] - Analysis using FOXD3 mouse mAb against NTERA-2 (1), HUVE-12 (2), HEK293 (3), Hela (4), Jurkat (5), K562 (6), RAW264.7 (7), NIH/3T3 (8), and COS7 (9) cell lysate.")
![Immunohistochemistry-Paraffin: FoxD3 Antibody (5G9) [NBP1-51685] - Analysis of paraffin-embedded lung cancer tissues (left) and ovarian cancer tissues (right) using FOXD3 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/FoxD3-Antibody-5G9-Immunohistochemistry-Paraffin-NBP1-51685-img0001.jpg)
![Western Blot: Bub1 Antibody (1A11C7) [NBP2-61719] - Analysis using BUB1 mAb against human BUB1 (AA: 1-130) recombinant protein. (Expected MW is 41.3 kDa)](http://images.novusbio.com/fullsize/Bub1-Antibody-1A11C7-Western-Blot-NBP2-61719-img0003.jpg "Western Blot: Bub1 Antibody (1A11C7) [NBP2-61719] - Analysis using BUB1 mAb against human BUB1 (AA: 1-130) recombinant protein. (Expected MW is 41.3 kDa)")
![Flow Cytometry: Bub1 Antibody (1A11C7) [NBP2-61719] - Analysis of Hela cells using BUB1 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/Bub1-Antibody-1A11C7-Flow-Cytometry-NBP2-61719-img0002.jpg)
![Western Blot: Bub1 Antibody (1A11C7) [NBP2-61719] - Analysis using BUB1 mAb against HEK293 (1) and BUB1 (AA: 1-130)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/Bub1-Antibody-1A11C7-Western-Blot-NBP2-61719-img0004.jpg)
![ELISA: Bub1 Antibody (1A11C7) [NBP2-61719] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/Bub1-Antibody-1A11C7-ELISA-NBP2-61719-img0001.jpg)
![Western Blot: CD16/CD32 Antibody (2G10A9) [NBP2-61693] - Analysis using CD16 mAb against human CD16 (AA: extra 17-208) recombinant protein. (Expected MW is 47.8 kDa)](http://images.novusbio.com/fullsize/CD16-CD32-Antibody-2G10A9-Western-Blot-NBP2-61693-img0003.jpg "Western Blot: CD16/CD32 Antibody (2G10A9) [NBP2-61693] - Analysis using CD16 mAb against human CD16 (AA: extra 17-208) recombinant protein. (Expected MW is 47.8 kDa)")
![Flow Cytometry: CD16/CD32 Antibody (2G10A9) [NBP2-61693] - Analysis of Ramos cells using CD16 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/CD16-CD32-Antibody-2G10A9-Flow-Cytometry-NBP2-61693-img0002.jpg)
![Western Blot: CD16/CD32 Antibody (2G10A9) [NBP2-61693] - Analysis using CD16 mAb against HEK293 (1) and CD16 (AA: extra 17-208)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/CD16-CD32-Antibody-2G10A9-Western-Blot-NBP2-61693-img0004.jpg)
![ELISA: CD16/CD32 Antibody (2G10A9) [NBP2-61693] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/CD16-CD32-Antibody-2G10A9-ELISA-NBP2-61693-img0001.jpg)
![Western Blot: DOT1L Antibody (OTI6E7) - Azide and BSA Free [NBP2-72298] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY DOT1L.](http://images.novusbio.com/fullsize/DOT1L-Antibody-OTI6E7-Azide-and-BSA-Free-Western-Blot-NBP2-72298-img0001.jpg "Western Blot: DOT1L Antibody (OTI6E7) - Azide and BSA Free [NBP2-72298] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY DOT1L.")
![Immunohistochemistry: DOT1L Antibody (OTI6E7) - Azide and BSA Free [NBP2-72298] - Analysis of Carcinoma of Human thyroid tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/DOT1L-Antibody-OTI6E7-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72298-img0002.jpg)
![Immunohistochemistry: DOT1L Antibody (OTI6E7) - Azide and BSA Free [NBP2-72298] - Analysis of Human thyroid tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/DOT1L-Antibody-OTI6E7-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72298-img0003.jpg)
![Western Blot: DOT1L Antibody (OTI1D8) - Azide and BSA Free [NBP2-72297] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY DOT1L.](http://images.novusbio.com/fullsize/DOT1L-Antibody-OTI1D8-Azide-and-BSA-Free-Western-Blot-NBP2-72297-img0001.jpg "Western Blot: DOT1L Antibody (OTI1D8) - Azide and BSA Free [NBP2-72297] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY DOT1L.")
![Immunohistochemistry: DOT1L Antibody (OTI1D8) - Azide and BSA Free [NBP2-72297] - Analysis of Carcinoma of Human kidney tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/DOT1L-Antibody-OTI1D8-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72297-img0002.jpg)
![Immunohistochemistry: DOT1L Antibody (OTI1D8) - Azide and BSA Free [NBP2-72297] - Analysis of Human lymphoma tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/DOT1L-Antibody-OTI1D8-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72297-img0003.jpg)
![Western Blot: Vimentin [p Ser71] Antibody (TM71) [NBP1-97515] - Analysis of phosphorylated vimentin (Ser71) expression in U251 using [pSer71]Vimentin, mAb (TM71).](http://images.novusbio.com/fullsize/Vimentin-p-Ser71-Antibody-TM71-Western-Blot-NBP1-97515-img0001.jpg "Western Blot: Vimentin [p Ser71] Antibody (TM71) [NBP1-97515] - Analysis of phosphorylated vimentin (Ser71) expression in U251 using [pSer71]Vimentin, mAb (TM71).")
![Immunocytochemistry/Immunofluorescence: Vimentin [p Ser71] Antibody (TM71) [NBP1-97515] - Analysis of phosphorylated vimentin (Ser71) on 4% PFA fixed U251 cells with [pSer71]Vimentin, mAb (TM71).](http://images.novusbio.com/fullsize/Vimentin-p-Ser71-Antibody-TM71-Immunohistochemistry-NBP1-97515-img0002.jpg)